PA
REAX icon

PharVision Advisers’s Real REMAX Group Inc. Common Stock REAX Stock Holding History

PharVision Advisers’s Portfolio REAX Stock Details REAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,099
Closed -$52.5K – 116
2026
Q1 		$52.5K Sell
2,099
-7,749
-79% -$234K 0.53% 87
2025
Q4 		$359K Buy
9,848
+3,889
+65% +$150K 0.18% 170
2025
Q3 		$249K Buy
+5,959
New +$269K 0.14% 333

Other funds holding REAX

MVPGP
Magma Venture Partners General Partner Tel Aviv, Israel $43.1M AUM 59.64% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $2.67B AUM 169.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return
GC
Grizzlyrock Capital Chicago, Illinois $143M AUM 6.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
WCM
Woodson Capital Management Greenwich, Connecticut $597M AUM 48.9% 1-Year Est. Return

PharVision Advisers's REAX Position: Q2 2026 in Review

PharVision Advisers sold out of Real REMAX Group Inc. Common Stock (REAX) in Q2 2026, closing a stake of 2,099 shares — an estimated $52.5K sold.

PharVision Advisers first reported a position in REAX in Q3 2025 and held it in 3 quarters. The position peaked at $359K in Q4 2025. 174 funds tracked by Wall St. Rank hold REAX as of Q2 2026.

  • PharVision Advisers reported no remaining Real REMAX Group Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
  • PharVision Advisers sold 2,099 Real REMAX Group Inc. Common Stock shares in Q2 2026, an estimated $52.5K.
  • PharVision Advisers first reported a position in Real REMAX Group Inc. Common Stock in Q3 2025 and held it in 3 quarters.
  • PharVision Advisers's Real REMAX Group Inc. Common Stock position peaked at $359K in Q4 2025.
  • 174 funds tracked by Wall St. Rank held Real REMAX Group Inc. Common Stock as of Q2 2026.

Based on PharVision Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.